Navigation Links
Clinically Proven Treatment Offers Help to Rosacea Sufferers
Date:4/15/2008

DUBLIN, April 15 /PRNewswire/ -- It is commonly known that many children get facial rashes, while teenagers tend to have acne - but as a person ages, their skin is supposed to clear up.

However, studies show there are millions of adults who still suffer from these kinds of facial skin conditions.

Derek Lepage [spokesperson with FaceDoctor] says:

"In the western hemisphere (rosacea) has not been addressed as a parasite, but as a bacterial infection."

"If a person with rosacea is treated for a bacterial infection, their skin will clear up while they are on medication, but the rash will come back because the parasite has not been treated. That's where FaceDoctor comes into play. The rosacea treament is a soap with a special ingredient that kills the parasite - seabuckthorn oil."

"The oil in the soap is clinically proven to destroy 80 per cent of the parasite on people with normal skin," Lepage says. "For people with rosacea, it allows their skin to return to its normal skin tone."

Studies have found that seabuckthorn oil has a nourishing, revitalizing and restorative action that can be used not only for acne but for dry, itchy skin, eczema, burns and cuts, as well as postpartum pigmentation.

Lepage explains, "After 30 years of research, doctors have found that the parasite linked with rosacea exists under the facial skin and in the hair follicle. The parasite feeds off the oil found inside the hair follicle.

"The redness appears when the parasite chews its way through an oil gland," he added. "The pore becomes enlarged and then plugged with bacteria and that's when acne develops."

Another myth associated with rosacea and acne rosacea is that it's hereditary. According to Lepage, that's just not true.

"People usually get (rosacea) through close contact with others when they are babies, such as mothers breastfeeding their children," he said. "The parasite can live under the skin and not appear for years."

The National Rosacea Society has found that the most common triggers for rosacea are sun exposure, emotional stress, hot or cold weather, wind, alcohol, spicy foods, heavy exercise, hot baths, heated beverages and certain skin-care products. In other words, almost anything that is potentially stimulating can be bad news.

For more information on the FaceDoctor soap, visit: http://www.facedoctor.biz

Contact :

Cormac Walsh +353-1-4966000

Email; facedoctoreurope@yahoo.co.uk


'/>"/>
SOURCE FaceDoctor
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
2. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
3. RediClinic Offers Affordable New Plan Clinically Shown to Double a Persons Chance to Stop Smoking
4. Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term
5. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
6. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
7. Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior
8. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
9. Microlifes Home Blood Pressure Monitors Proven Accurate Even for Critical Patients
10. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
11. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Research and Markets has announced ... (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By Country ... ... forecasted to grow at a CAGR of 5.33% during 2016-2021 ... infectious diseases along with surging demand of digital thermometer. Apart from ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced that KCP-400 (RgIA4), a potent antagonist ... robust chronic pain relief and disease modifying effects ... the a9a10 nAChR as a new, non-opioid target ... were reported online in the February 20 th ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... A product of ... seem to derive a heart-protective benefit from eating soy foods, while others do not, ... men who are able to produce equol—a substance made by some types of “good” ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Super-Sod will attend ... 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show ... , For the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Social media ... especially for hospitals and health systems. Smith & Jones’ delves into this insight and ... episode, President of Smith & Jones David Vener meets up with social media strategist ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a ... Medical University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, ... on Aging is a tremendous resource in our community. We are thrilled to participate ...
Breaking Medicine News(10 mins):